Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200

Cell Host and Microbe

Volumn 9, Issue 6, 2011, Pages 463-471

  Cortez, Mauro ^a,b   Huynh, Chau ^a,b   Fernandes, Maria Cecilia ^a   Kennedy, Kathleen A ^c   Aderem, Alan ^c   Andrews, Norma W ^a,b  

^a University of Maryland   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD200 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIVISION; CONTROLLED STUDY; HEALING; HOST; LEISHMANIA; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PARASITE SURVIVAL; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD; FEMALE; GENE EXPRESSION; HOST-PARASITE INTERACTIONS; HUMANS; LEISHMANIA; LEISHMANIASIS; MACROPHAGES; MICE; MICE, INBRED C57BL; NITRIC OXIDE; VIRULENCE;

LEISHMANIA AMAZONENSIS; LEISHMANIA MAJOR; MUS;

EID: 79958761668     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2011.04.014     Document Type: Article

References (49)

1. Afonso, L.C., and Scott, P. (1993). Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61, 2952-2959.
2. Balestieri, F.M., Queiroz, A.R., Scavone, C., Costa, V.M., Barral-Netto, M., and Abrahamsohn, Ide.A. (2002). Leishmania (L.) amazonensis-induced inhibition of nitric oxide synthesis in host macrophages. Microbes Infect. 4, 23-29.
3. Banerjee, D., and Dick, A.D. (2004). Blocking CD200-CD200 receptor axis augments NOS-2 expression and aggravates experimental autoimmune uveoretinitis in Lewis rats. Ocul. Immunol. Inflamm. 12, 115-125.
4. Barclay, A.N., Wright, G.J., Brooke, G., and Brown, M.H. (2002). CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol. 23, 285-290. (Pubitemid 34628770)
5. Barral, A., Pedral-Sampaio, D., Grimaldi Júnior, G., Momen, H., McMahon-Pratt, D., Ribeiro de Jesus, A., Almeida, R., Badaro, R., Barral-Netto, M., Carvalho, E.M., et al. (1991). Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am. J. Trop. Med. Hyg. 44, 536-546.
6. Becker, S.M., Delamarre, L., Mellman, I., and Andrews, N.W. (2009). Differential role of the Ca(2+) sensor synaptotagmin VII in macrophages and dendritic cells. Immunobiology 214, 495-505.
7. Belkaid, Y., Mendez, S., Lira, R., Kadambi, N., Milon, G., and Sacks, D. (2000). A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J. Immunol. 165, 969-977.
8. Belosevic, M., Finbloom, D.S., Van Der Meide, P.H., Slayter, M.V., and Nacy, C.A. (1989). Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143, 266-274. (Pubitemid 19174230)
9. Blos, M., Schleicher, U., Soares Rocha, F.J., Meissner, U., Röllinghoff, M., and Bogdan, C. (2003). Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase. Eur. J. Immunol. 33, 1224-1234.
10. Bogdan, C., Röllinghoff, M., and Diefenbach, A. (2000). The role of nitric oxide in innate immunity. Immunol. Rev. 173, 17-26.
11. Boggiatto, P.M., Jie, F., Ghosh, M., Gibson-Corley, K.N., Ramer-Tait, A.E., Jones, D.E., and Petersen, C.A. (2009). Altered dendritic cell phenotype in response to Leishmania amazonensis amastigote infection is mediated by MAP kinase, ERK. Am. J. Pathol. 174, 1818-1826.
12. Buxbaum, L.U. (2010). Type I IFNs promote the early IFN-gamma response and the IL-10 response in Leishmania mexicana infection. Parasite Immunol. 32, 153-160.
13. Cameron, C.M., Barrett, J.W., Liu, L., Lucas, A.R., and McFadden, G. (2005). Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivo. J. Virol. 79, 6052-6067. (Pubitemid 40617211)
14. Copland, D.A., Calder, C.J., Raveney, B.J., Nicholson, L.B., Phillips, J., Cherwinski, H., Jenmalm, M., Sedgwick, J.D., and Dick, A.D. (2007). Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am. J. Pathol. 171, 580-588.
15. Diefenbach, A., Schindler, H., Donhauser, N., Lorenz, E., Laskay, T., MacMicking, J., Röllinghoff, M., Gresser, I., and Bogdan, C. (1998). Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8, 77-87. (Pubitemid 28097825)
16. Foster-Cuevas, M., Wright, G.J., Puklavec, M.J., Brown, M.H., and Barclay, A.N. (2004). Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. J. Virol. 78, 7667-7676. (Pubitemid 38915913)
17. Gomes, I.N., Calabrich, A.F., Tavares, Rda.S., Wietzerbin, J., de Freitas, L.A., and Veras, P.S. (2003). Differential properties of CBA/J mononuclear phagocytes recovered from an inflammatory site and probed with two different species of Leishmania. Microbes Infect. 5, 251-260. (Pubitemid 36428714)
18. Green, S.J., Crawford, R.M., Hockmeyer, J.T., Meltzer, M.S., and Nacy, C.A. (1990). Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J. Immunol. 145, 4290-4297.
19. Hatherley, D., and Barclay, A.N. (2004). The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains. Eur. J. Immunol. 34, 1688-1694.
20. Hoek, R.M., Ruuls, S.R., Murphy, C.A., Wright, G.J., Goddard, R., Zurawski, S.M., Blom, B., Homola, M.E., Streit, W.J., Brown, M.H., et al. (2000). Downregulation of the macrophage lineage through interaction with OX2 (CD200). Science 290, 1768-1771. (Pubitemid 32004808)
21. Iniesta, V., Gómez-Nieto, L.C., and Corraliza, I. (2001). The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages. J. Exp. Med. 193, 777-784.
22. Jones, D.E., Buxbaum, L.U., and Scott, P. (2000). IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J. Immunol. 165, 364-372. (Pubitemid 30429528)
23. Jones, D.E., Ackermann, M.R., Wille, U., Hunter, C.A., and Scott, P. (2002). Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect. Immun. 70, 2151-2158.
24. Koblish, H.K., Hunter, C.A., Wysocka, M., Trinchieri, G., and Lee, W.M. (1998). Immune suppression by recombinant interleukin (rIL)-12 involves interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect. J. Exp. Med. 188, 1603-1610.
25. Kuang, Z., Yao, S., Xu, Y., Lewis, R.S., Low, A., Masters, S.L., Willson, T.A., Kolesnik, T.B., Nicholson, S.E., Garrett, T.J., and Norton, R.S. (2009). SPRY domain-containing SOCS box protein 2: crystal structure and residues critical for protein binding. J. Mol. Biol. 386, 662-674.
26. Liew, F.Y., Millott, S., Parkinson, C., Palmer, R.M., and Moncada, S. (1990). Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144, 4794-4797. (Pubitemid 20224118)
27. MacMicking, J., Xie, Q.W., and Nathan, C. (1997). Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350.
28. Mattner, J., Schindler, H., Diefenbach, A., Röllinghoff, M., Gresser, I., and Bogdan, C. (2000). Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major. Eur. J. Immunol. 30, 2257-2267.
29. McMahon-Pratt, D., and Alexander, J. (2004). Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol. Rev. 201, 206-224. (Pubitemid 39318454)
30. Mukhopadhyay, S., Plüddemann, A., Hoe, J.C., Williams, K.J., Varin, A., Makepeace, K., Aknin, M.L., Bowdish, D.M., Smale, S.T., Barclay, A.N., and Gordon, S. (2010). Immune inhibitory ligand CD200 induction by TLRs and NLRs limits macrophage activation to protect the host from meningococcal septicemia. Cell Host Microbe 8, 236-247.
31. Muleme, H.M., Reguera, R.M., Berard, A., Azinwi, R., Jia, P., Okwor, I.B., Beverley, S., and Uzonna, J.E. (2009). Infection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis. J. Immunol. 183, 8068-8076.
32. Nasseri, M., and Modabber, F.Z. (1979). Generalized infection and lack of delayed hypersensitivity in BALB/c mice infected with Leishmania tropica major. Infect. Immun. 26, 611-614.
33. Pinto-da-Silva, L.H., Fampa, P., Soares, D.C., Oliveira, S.M., Souto-Padron, T., and Saraiva, E.M. (2005). The 3A1-La monoclonal antibody reveals key features of Leishmania (L) amazonensis metacyclic promastigotes and inhibits procyclics attachment to the sand fly midgut. Int. J. Parasitol. 35, 757-764.
34. Qadoumi, M., Becker, I., Donhauser, N., Röllinghoff, M., and Bogdan, C. (2002). Expression of inducible nitric oxide synthase in skin lesions of patients with american cutaneous leishmaniasis. Infect. Immun. 70, 4638-4642.
35. Qi, H., Ji, J., Wanasen, N., and Soong, L. (2004). Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis. Infect. Immun. 72, 988-995.
36. Ravetch, J.V., and Lanier, L.L. (2000). Immune inhibitory receptors. Science 290, 84-89.
37. Reiner, S.L., and Locksley, R.M. (1995). The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13, 151-177.
38. Sacks, D.L., and Melby, P.C. (2001). Animal models for the analysis of immune responses to leishmaniasis. Curr. Protoc. Immunol. 19, 2.
39. Sacks, D., and Noben-Trauth, N. (2002). The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2, 845-858.
40. Scott, P., and Sher, A. (1986). A spectrum in the susceptibility of leishmanial strains to intracellular killing by murine macrophages. J. Immunol. 136, 1461-1466. (Pubitemid 16156257)
41. Shankar, A.H., Morin, P., and Titus, R.G. (1996). Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice. Exp. Parasitol. 84, 136-143.
42. Snelgrove, R.J., Goulding, J., Didierlaurent, A.M., Lyonga, D., Vekaria, S., Edwards, L., Gwyer, E., Sedgwick, J.D., Barclay, A.N., and Hussell, T. (2008). A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat. Immunol. 9, 1074-1083.
43. Stenger, S., Donhauser, N., Thüring, H., Röllinghoff, M., and Bogdan, C. (1996). Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 183, 1501-1514.
44. Titus, R.G., Marchand, M., Boon, T., and Louis, J.A. (1985). A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7, 545-555. (Pubitemid 16256170)
45. Wei, X.Q., Charles, I.G., Smith, A., Ure, J., Feng, G.J., Huang, F.P., Xu, D., Muller, W., Moncada, S., and Liew, F.Y. (1995). Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411.
46. Wilkins-Rodríguez, A.A., Escalona-Montaño, A.R., Aguirre-García, M., Becker, I., and Gutiérrez-Kobeh, L. (2010). Regulation of the expression of nitric oxide synthase by Leishmania mexicana amastigotes in murine dendritic cells. Exp. Parasitol. 126, 426-434.
47. Wilson, J., Huynh, C., Kennedy, K.A., Ward, D.M., Kaplan, J., Aderem, A., and Andrews, N.W. (2008). Control of parasitophorous vacuole expansion by LYST/Beige restricts the intracellular growth of Leishmania amazonensis. PLoS Pathog. 4, e1000179.
48. Wright, G.J., Puklavec, M.J., Willis, A.C., Hoek, R.M., Sedgwick, J.D., Brown, M.H., and Barclay, A.N. (2000). Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13, 233-242.
49. Xin, L., Li, K., and Soong, L. (2008). Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes. Mol. Immunol. 45, 3371-3382.